By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Key Highlights of Biology today

النقاط الرئيسية of Chemistry today

Key Highlights of Chemistry today

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Today’s Neurology Science Briefing | March 28th 2026, 1:00:14 pm

Medicine

Today’s Neurology Science Briefing | March 28th 2026, 1:00:14 pm

Last updated: March 28, 2026 12:24 pm
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
A study found that a specific brain structure pattern—enlarged ventricles combined with cognitive impairment—is a rare but distinct feature seen mostly in patients with schizophrenia, rather than across other psychiatric conditions. This suggests a unique biological link between this brain abnormality and schizophrenia, which could help in better understanding and diagnosing the illness.
Source →

•
Researchers identified a new genetic cause for a painful bone inflammation condition in children, linking it to a deficiency in the OGFRL1 protein which leads to overactive bone-destroying cells. This discovery not only explains the mechanism of the disease but also showed that patients responded well to treatment with a common anti-inflammatory drug, offering a direct path to better therapy.
Source →

•
A major clinical trial showed that adding chemotherapy to a targeted drug significantly delayed cancer progression in lung cancer patients who have both an EGFR mutation and additional tumor suppressor gene mutations. This finding is crucial because it provides the first evidence for a more effective, personalized treatment strategy for this specific group of patients who typically do worse on standard therapy.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Public Health Science Briefing | March 28th 2026, 1:00:14 pm
Next Article Today’s Clinical Medicine Science Briefing | March 28th 2026, 1:00:14 pm
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The heterogeneous treatment effects of statins on dementia: a target trial emulation with causal machine learning using integrated genetic and real‐world data

The pancreatic cancer drug market: navigating a complex therapeutic landscape

La psoriasis en EE.UU.: una enfermedad con rostro regional

A correction in the record: clarifying a key researcher’s affiliations

A Cytokine Compass: IL-18 Levels Chart the Course of Still Disease

A New Target for Chronic Pain: Halting Microglial Pruning in the Brain

Today’s Neurology Science Briefing | March 21st 2026, 1:00:12 pm

The Clock of Labor: How Prolonged Active Phase Predicts Maternal and Neonatal Risk

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Gastroenterology
  • Social Sciences
  • Surgery
  • Natural Language Processing
  • Cell Biology
  • Engineering
  • Genetics
  • Immunology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?